Background and Goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...
Background and goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...
NEW YORK & DUBLIN--(BUSINESS WIRE)--Feb. 24, 2012-- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that it has been granted European ...
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
Twister is Aptar Pharma's new dry powder inhaler--courtesy Aptar Pharma Just in time for World Asthma Day, Aptar Pharma ($ATR) is launching a capsule-based dry powder ...
The flurry of business development activity at Aptar continues. Having made moves for injectable drug delivery and digital therapeutic players in recent weeks, Aptar has now nabbed (PDF) an option on ...
Dry Powder Inhalers (DPIs) are employed to supply a safe dose of Active Pharmaceutical Ingredient (API) to the deep lung. Image Credit: Freeman Technology An excipient transports the delicate ...
MedPage Today on MSN
FDA approves generic Flovent inhaler for asthma
Move comes 2 years after controversial exit of brand-name product ...
The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results